Efficacy and Safety of Vitamin K-Antagonists (VKA) for Atrial Fibrillation in Non-Dialysis Dependent Chronic Kidney Disease

• Judith Kooiman ,

  * E-mail: j.kooiman@lumc.nl

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Nienke van Rein,

  Affiliations Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands, Einthoven Laboratory of Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Bas Spaans,

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Koen A. J. van Beers,

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Jonna R. Bank,

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Wilke R. van de Peppel,

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Antonio Iglesias del Sol,

  Affiliation Department of Internal Medicine, Rijnland Hospital, Leiderdorp, The Netherlands

  ⨯
• Suzanne C. Cannegieter,

  Affiliation Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Ton J. Rabelink,

  Affiliation Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Gregory Y. H. Lip,

  Affiliation Haemostasis, Thrombosis, and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom

  ⨯
• Frederikus A. Klok,

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Menno V. Huisman

  Affiliation Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯